NCT04080076View on ClinicalTrials.gov

Comparative and Efficacy Study of ACTHar Gel Alone or in Combination With Tacrolimus in Fibrillary Glomerulopathy

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

January 12, 2019

Primary Completion Date

September 6, 2024

Study Completion Date

September 6, 2024

Conditions
Renal Disease
Interventions
DRUG

Acthar 80 UNT/ML Injectable Solution

ACTHar 80 Units SQ 1042 x Week

DRUG

Oral Tab Tacrolimus

Oral Tab Tacrolimus (1.0 mg PO BID) in combination with ACTHar 80 Units SQ 2 X week

Trial Locations (1)

30046

Georgia Nephrology Research Institute, Lawrenceville

Sponsors

Collaborators (1)

Mallinckrodt
All Listed Sponsors
collaborator

Mallinckrodt

INDUSTRY

lead

NephroNet, Inc.

OTHER